August 14, 2026 · earnings
ATNM earnings: a positive outcome, +8.3%
On August 14, 2026, Actinium Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +8.3% in the window around the event. It had already run -14.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$0.96
1d before
$1.04
Event day
$1.04
1d after
$1.13
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.6% expected); the stock actually moved +8.3%. Model confidence at the time: 40%.
See the full scored track recordPre-catalyst setup
-14.1%
30-day run-up
7744%
30-day volatility
2.4×
volume spike